Hemostatic Pad Industry to Witness Steady Growth Rate During ... - Argyle Report
| 246960 Stock | KRW 8,480 40.00 0.47% |
About 54% of InnoTherapy's investor base is interested to short. The analysis of current outlook of investing in InnoTherapy suggests that many traders are impartial regarding InnoTherapy's prospects. The current market sentiment, together with InnoTherapy's historical and current headlines, can help investors time the market. In addition, many technical investors use InnoTherapy stock news signals to limit their universe of possible portfolio assets.
InnoTherapy |
Hemostatic Pad Industry to Witness Steady Growth Rate During ... Argyle Report
Read at news.google.com
 |
InnoTherapy Fundamental Analysis
We analyze InnoTherapy's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of InnoTherapy using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of InnoTherapy based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
InnoTherapy is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
InnoTherapy Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with InnoTherapy stock to make a market-neutral strategy. Peer analysis of InnoTherapy could also be used in its relative valuation, which is a method of valuing InnoTherapy by comparing valuation metrics with similar companies.
Peers
InnoTherapy Related Equities
| 109960 | Aprogen Healthcare | 8.42 | ||||
| 058630 | Mgame Corp | 8.24 | ||||
| 025890 | Hankook Steel | 7.56 | ||||
| 293490 | Kakao Games | 3.53 | ||||
| 017480 | Samhyun Steel | 0.43 | ||||
| 008420 | Moonbae Steel | 0.39 | ||||
| 039240 | Gyeongnam Steel | 0.98 | ||||
| 004105 | Taeyang Metal | 5.91 |
Complementary Tools for InnoTherapy Stock analysis
When running InnoTherapy's price analysis, check to measure InnoTherapy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InnoTherapy is operating at the current time. Most of InnoTherapy's value examination focuses on studying past and present price action to predict the probability of InnoTherapy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InnoTherapy's price. Additionally, you may evaluate how the addition of InnoTherapy to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |